Lanzostad (Lansoprazole)

Lansoprazole selectively and irreversibly blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition stops the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose of Lanzostad is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage may vary for different indications and should follow the prescriber’s instructions.

Safety data for lansoprazole in pregnancy and lactation are limited. The prescriber should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To request Lanzostad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lanzostad (lansoprazole) belongs to the same class as omeprazole, esomeprazole, pantoprazole and rabeprazole. All PPIs suppress gastric acid, but differences exist in pharmacokinetics, potency, and drug‑interaction profiles. Lansoprazole offers a rapid onset of action and is often chosen for its efficacy in Helicobacter pylori regimens.

Store Lanzostad at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Lanzostad is taken orally, usually as a whole tablet with a glass of water. It is generally recommended to swallow the tablet before a meal, unless the prescriber advises otherwise. Do not crush, chew, or split the tablet unless instructed.

Serious risks, though uncommon, include severe allergic reactions (e.g., anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, liver enzyme elevations, and rare skin disorders such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Lanzostad should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking medications that require an acidic gastric environment, and patients with a history of certain infections or electrolyte disturbances.